ICON REPORTS LVC PROCEDURE GROWTH RATE UP 270% YR-TO-YR.(Brief
Article)(Statistical Data Included)
ICON Laser Eye Centers, Inc. (CDN:ILEcu.)(OTC CDN: ILEC.U-
Canadian Dealers Network) ("ICON"), Toronto, a leading
international laser vision correction ("LVC") provider has
announced that 23,491 . . .
IMMTECH REPORTS NET LOSS FOR 4TH QTR. AND FISCAL 2000.(Brief
Article)(Statistical Data Included)
Immtech International Inc. (NASDAQ NMS:IMMT), Vernon Hills, Ill.,
a biopharmaceutical company focused on the delivery and
commercialization of drugs for the treatment of fungal diseases, . . .
SYNSORB BIOTECH REPORTS NET INCOME OF $137,000 FOR FIRST
QTR.
SYNSORB Biotech Inc. ("SYNSORB") (TSE:SYB, NASDAQ:SYBB),
Calgary, Alberta, has reported net income for the quarter ended March
31, 2000 of $137,000 or $0.004 per share compared to a loss . . .
BAUSCH & LOMB DECLARES QUARTERLY DIVIDEND.
Bausch & Lomb (NYSE/BOL), Rochester, N.Y., has declared a
regular quarterly dividend of 26 cents per share on the common stock of
the company.
The dividend is payable July 3, 2000 to . . .
MAXIM PHARMACEUTICALS ADOPTS SHAREHOLDER RIGHTS PLAN.
Maxim Pharmaceuticals (Nasdaq NM:MAXM)(SSE:MAXM), San Diego, has
announced that its board of directors has adopted a shareholder rights
plan designed to protect the company's shareholders in the . . .
OAK HILL CAPITAL PARTNERS INVESTS IN ALIGN TECHNOLOGY.(Brief
Article)
Oak Hill Capital Partners, L.P., New York, a private equity
investment group founded by Robert M. Bass, has announced that it is a
lead investor in a $105 million financing round in Align . . .
INTERLEUKIN GENETICS REPORTS FIRST QTR. NET LOSS.(Brief
Article)
Interleukin Genetics, Inc. (NASDAQ:ILGN), San Antonio, has
reported financial results for the quarter ended March 31, 2000. For the
quarter, the company reported a net loss of $1,246,036 (a loss . . .
UNIVEC FIRST QTR. SALES RISE 140% OVER SAME QTR. LAST
YEAR.
The UNIVEC Corporation (NASDAQ:UNVC), Farmingdale, N.Y., one of
the world's leading manufacturers of auto-destruct syringes, has
reported first quarter 2000 sales of $839,409, a 140% increase . . .
LJL BIOSYSTEMS'FIRST QTR. REVENUES UP 129% COMPARED TO
1999.(Brief Article)(Statistical Data Included)
LJL BioSystems, Inc. (Nasdaq: LJLB), Sunnyvale, Calif., a leading
provider of infrastructure tools for accelerating drug discovery, has
announced record financial results for the first quarter, . . .
MERCK'S FIRST QTR. EARNINGS PER SHARE INCREASE 17%.(Brief
Article)(Statistical Data Included)
Merck & Co., Inc., Whitehouse station, N.J., has announced
that earnings per share for the first quarter of 2000 were $0.63, an
increase of 17% over the first quarter of 1999. First quarter net . . .
ICOS REPORTS NET LOSS OF $11.9 MILLION FOR FIRST QTR.(Brief
Article)(Statistical Data Included)
For the first quarter of 2000, ICOS Corporation (Nasdaq:ICOS),
Bothell, Wash., has reported a net loss of $11.9 million, or $0.26 per
share, compared to a net loss of $7.2 million, or $0.17 per . . .
AMGEN REPORTS 9% INCREASE IN FIRST QTR. EARNINGS PER
SHARE.(Statistical Data Included)
Amgen (Nasdaq:AMGN), Thousand Oaks, Calif., has announced that
earnings per share for the first quarter ended March 31, 2000 increased
9 percent, to $0.25 from $0.23 for the first quarter of 1999. . . .
US DIAGNOSTIC REPORTS $8.2 MILLION NET LOSS FOR 1999.(Brief
Article)(Statistical Data Included)
US Diagnostic Inc. (Nasdaq:USDL), West Palm Beach, Fla., has
reported its financial results for the year ended December 31, 1999.
Net revenues for 1999 were $155.6 million compared to $195.7 . . .
ELECTROPHARMACOLOGY REPORTS 1999 NET LOSS OF $703,000.(Brief
Article)(Statistical Data Included)
Electropharmacology, Inc. (EPi) (OTCBB:EPHI), Alachua, Fla., has
reported its unaudited financial results for the year ending December
31, 1999. Unaudited annual revenues from the sale of custom . . .
NEORX REPORTS NET LOSS OF $2.4 MILLION FOR 1ST QTR 2000.(Brief
Article)(Statistical Data Included)
NeoRx Corporation (Nasdaq:NERX), Seattle, Wash., has reported a
net loss of $2.4 million ($0.12 diluted per share loss after preferred
dividends) for the first quarter of 2000, compared to a net . . .
GENENTECH REPORTS 21% INCREASE IN 1ST QTR PRODUCT SALES.(Brief
Article)(Statistical Data Included)
Genentech, Inc. (NYSE:DNA), South San Francisco, has announced a
21 percent increase in product sales and a 27 percent increase in
earnings per share for the first quarter of 2000, exclusive of . . .
BIOMARIN REPORTS 1999 YEAR-END NET LOSS.(Brief
Article)(Statistical Data Included)
BioMarin Pharmaceutical Inc. (Nasdaq and Swiss SWX New Market:
BMRN), Novato, Calif., has announced financial results for the fourth
quarter and the full year ended December 31, 1999.
1999 Full . . .
LIFECELL REPORTS 1999 PRODUCT SALES INCREASE 64% OVER 1998.(Brief
Article)(Statistical Data Included)
LifeCell Corporation (Nasdaq:LIFC), Branchburg, N.J., has
announced that total product sales increased 64% in 1999 to $11.9
million as compared to $7.2 million in 1998, while gross margin . . .
BIOVAIL REPORTS RECORD 1999 4TH QTR/YEAR-END RESULTS.(Brief
Article)(Statistical Data Included)
Biovail Corporation (NYSE:BVF)(TSE:BVF), Toronto, has reported
record fourth quarter and year end financial results for the period
ended December 31, 1999.
Revenue for the fourth quarter of 1999 . . .
ILEX ONCOLOGY'S 1999 REVENUE INCREASED 25% TO 17.9
MILLION.(Brief Article)(Statistical Data Included)
ILEX(tm) Oncology Inc. (Nasdaq:ILXO), San Antonio, Texas, has
reported operating highlights and financial results for the quarter and
year ended Dec. 31, 1999. "1999 was a pivotal year for . . .
|
|